Answers are grounded in this paper and cite their sources.
A correction was issued for the trial comparing magnetic seizure therapy and electroconvulsive therapy in depression, indicating a data change.
Blumberger DM, McClintock SM, Thorpe KE, et al. Confirmatory efficacy and safety trial of magnetic seizure therapy versus right unilateral ultra-brief electroconvulsive therapy in depression (CREST–MST): a randomised, double-blind, non-inferiority trial in Canada and the USA. Lancet Psychiatry 2026; 13: 376–86—In table 2 of this Article, the last section should have had the scale 1–7 and the ultimate row of data should have been “Very much worse (7)” with 0 in the “End” column in both arms. This correction has been made to the online version as of April 16, 2026.
No takes yet. Share an insight, caveat, or question.
A 2026 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: